Inici › Malaltia cardiovascular › Florida › Orlando
Assaigs clínics de Malaltia cardiovascular a Orlando, FL
14 estudis de Malaltia cardiovascular busquen participants en centres de Orlando i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
ReclutantFase 2
- Florida Institute For Clinical Research, LLC, Orlando
- K2 Medical Research - Maitland, Maitland · a 6 mi
- Omega Research Orlando, Altamonte Springs · a 9 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
ReclutantFase 3
- Florida Institute for Clinical Research, Orlando
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
ReclutantFase 3
- Clinical Site Partners, LLC dba Flourish Research, Winter Park · a 5 mi
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
ReclutantFase 3
- Clinical Trial Site, Orlando
- Clinical Trial Site, Winter Park · a 5 mi
A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
ReclutantFase 3
- Clinical Research Site, Kissimmee · a 16 mi
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Reclutant
- Advent Health, Orlando
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
ReclutantFase 2
- Clinical Research Site, Kissimmee · a 16 mi
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
ReclutantEstudi observacional
- Arnold Palmer Hospital for Children, Orlando
- Nemours Children's Hospital, Orlando
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
ReclutantFase 3
- Research Site, Orlando
- Research Site, Orlando
- Research Site, Orlando
- i 2 més
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
ReclutantFase 3
- Clinical Site Partners Orlando dba Flourish Research, Winter Park · a 5 mi
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
ReclutantFase 3
- FC Site Partners Miami, Winter Park · a 5 mi
SPYRAL GEMINI Pilot Study
Reclutant
- Orlando Health Heart & Vascular Institute, Orlando
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Reclutant
- Advent Health Hospital, Orlando
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
ReclutantFase 3
- AdventHealth, Orlando
Assaigs de Malaltia cardiovascular en altres ciutats
- Boston, MA37 estudis
- New York City, NY33 estudis
- Washington, DC29 estudis
- Houston, TX24 estudis
- Dallas, TX23 estudis
- Atlanta, GA22 estudis
- Cleveland, OH22 estudis
- Chicago, IL21 estudis
- Philadelphia, PA21 estudis
- Pittsburgh, PA20 estudis
- St. Louis, MO20 estudis
- San Francisco, CA18 estudis
Altres estudis a Orlando
- Càncer de pulmó de cèl·lules no petites44 estudis
- Obesitat31 estudis
- Càncer metastàtic29 estudis
- Sobrepès27 estudis
- Malaltia d'Alzheimer25 estudis
- Diabetis tipus 224 estudis
- Càncer (tots els tipus)24 estudis
- Càncer de mama23 estudis
- Càncer d'ovari22 estudis
- Colitis ulcerosa22 estudis
- Càncer de pulmó21 estudis
- Càncer colorrectal19 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.